Crikey - this is really great news - and an outstanding result.
Four out of seven patients (Cohort B, see ASX announcement 2 September 2024)
have now achieved a complete response following treatment with azer-cel,
lymphodepletion (chemotherapy), and low-dose interleukin 2 (IL-2)
Add to My Watchlist
What is My Watchlist?